Background & Aims Some patients with SARS-CoV-2 infection have abnormal liver function.
We aimed to clarify the features of COVID-19-related liver damage to provide references for …

Cytomegalovirus (CMV) infection is a common infection in adults (seropositive 60–99%
globally), and is associated with cardiovascular diseases, in line with risk factors such as …

COVID‐19 has become a global pandemic and garnered international attention. Although the
clinical features of COVID‐19‐related liver injury have been investigated, there have been …

To facilitate the delivery of nucleotide-based therapeutics to cells and tissues, a variety of
pronucleotide approaches have been developed. Our laboratory and others have …

Agricultural production consumes the majority of global freshwater resources. The worsening
water scarcity has imposed significant stress on agricultural production when regions seek …

Hepatitis B virus (HBV) is the major causative agent of chronic hepatitis, hepatic decompensation,
liver cirrhosis, and hepatocellular carcinoma (HCC). HBV-related serum markers are …

Background & Aims It is unclear whether liver stiffness measurement ( LSM ) dynamic
changes after anti‐ HBV treatment could predict the risk of liver‐related events ( LRE s), …

Background: Thymosin alpha-1 (Ta-1) suppresses HBV viral replication, while the evidence
of combination effect with nucleoide is still limited. We aimed to investigate the efficacy and …

Chronic hepatitis B (CHB) virus infection can cause persistent hepatic inflammation and
cirrhosis, which may lead to hepatocellular carcinoma (HCC). CHB is considered the dominant …

It is unknown whether dynamic changes of liver stiffness measurement ( LSM ) can predict
the reversibility of fibrosis. Therefore, we evaluated the utility of LSM changes in predicting …